Biocorrx Operating Income 2012-2024 | BICX

Biocorrx operating income from 2012 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.

Biocorrx Operating Income 2012-2024 | BICX

Biocorrx operating income from 2012 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
Related Stocks
Company NameMarket
Cap
Danaher (DHR)$133.5B
Elevance Health (ELV)$96.1B
CVS Health (CVS)$84.8B
Cencora (COR)$55.6B
DiDi Global (DIDIY)$20.3B
Natera (NTRA)$20B
BioMerieux (BMXMF)$15.6B
Solventum (SOLV)$11.5B
ICON (ICLR)$11.3B
EUROFINS SCIENT (ERFSF)$11.1B
Revvity (RVTY)$11B
CochLear (CHEOY)$10.9B
Avantor (AVTR)$10.3B
Doximity (DOCS)$9.9B
Viatris (VTRS)$9B
Medpace Holdings (MEDP)$9B
Sonic Healthcare (SKHHY)$7.7B
HealthEquity (HQY)$7.3B
Charles River Laboratories (CRL)$5.2B
Amplifon S.p.A (AMFPF)$4.3B
Bausch + Lomb (BLCO)$4.3B
Alignment Healthcare (ALHC)$3.5B
Sotera Health (SHC)$3B
BrightSpring Health Services (BTSG)$2.9B
Organon (OGN)$2.9B
Surgery Partners (SGRY)$2.7B
GeneDx Holdings (WGS)$2.7B
Concentras Parent (CON)$2.6B
Progyny (PGNY)$1.8B
Ardent Health Partners (ARDT)$1.8B